APA (7th ed.) Citation

Dong, Y., Tschoegl, M., Lehner, F., Santol, J., Notte, F., Gramberger, M., . . . Gruenberger, T. (2026). Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases. Cancers, 18(3), 521. https://doi.org/10.3390/cancers18030521

Chicago Style (17th ed.) Citation

Dong, Yawen, et al. "Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases." Cancers 18, no. 3 (2026): 521. https://doi.org/10.3390/cancers18030521.

MLA (9th ed.) Citation

Dong, Yawen, et al. "Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases." Cancers, vol. 18, no. 3, 2026, p. 521, https://doi.org/10.3390/cancers18030521.